OJD  Vol.3 No.1 , February 2014
Psychiatric Doubts
Abstract: doubts
Keywords: psychiatric
Cite this paper: Cocchi, M. , Tonello, L. & Gabrielli, F. (2014). Psychiatric Doubts. Open Journal of Depression, 3, 5-8. doi: 10.4236/ojd.2014.31003.

[1]   Bowden, C. L. (2001). Strategies to reduce misdiagnosis of bipolar depression. Psychiatrical Services, 52, 51-55.

[2]   Cocchi, M., Tonello, L., & Rasenick, M. M. (2010). Human depression: A new approach in quantitative psychiatry. Annals of General Psychiatry, 9, 25.

[3]   Cocchi, M., & Tonello, L. (2010). Bio molecular considerations in Major Depression and Ischemic Cardiovascular Disease. Central Nervous System Agents in Medicinal Chemistry, 10, 97-107.

[4]   Cocchi, M., Tonello, L., Tsaluchidu, S., & Puri, B. K. (2008). The use of artificial neural networks to study fatty acids in neuropsychiatric disorders. BMC Psychiatry, 8, S3.

[5]   Coleman, M. (1971). Platelet serotonin in disturbed monkeys and children. Clinical Process of Children’s Hospital, 27, 187-194.

[6]   Takahashi, S. (1976). Reduction of blood platelet serotonin levels in manic and depressed patients. Folia Psychiatrica et Neurologica Japonica, 30, 475-486.

[7]   Sthal, S. M. (1977). The human platelet. A diagnostic and research tool for the study of biogenic amines in psychiatric and neurologic disorders. Archives of General Psychiatry, 34, 509-516.

[8]   Kim, H. L., Plaisant, O., Leboyer, M., Gay, C., Kamal, L., Devynck, M. A., & Meyer, P. (1982). Reduction of platelet serotonin in major depression (endogenous depression). Comptes Rendus de l’Académie des Sciences III, 295, 619-622.

[9]   Dreux, C., & Launay, J. M. (1985). Blood platelets: Neuronal model in psychiatric disorders. Encephale, 11, 57-64.

[10]   Arora, R. C., & Meltzer, H. Y. (1989). Increased serotonin 2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3HLSD) in the blood platelets of depressed patients. Life Science, 44, 725-734.

[11]   Thompson, P. (1999). Platelet and erythrocyte membrane and fluidity changes in alcohol dependent patients undergoing acute withdrawal. Alcohol and Alcoholism, 3, 349-354.

[12]   Camacho, A., & Dimsdale, J. E. (2000). Platelets and psychiatry: Lessons learned from old and new studies. Psychosomatic Medicine, 62, 326-336.

[13]   Plein, H., & Berk, M. (2001). The platelet as a peripheral marker in psychiatric illness. Clinical and Experimental Pharmacology and Physiology, 16, 229-236.

[14]   McEwen, B. S. (1999). Stress and hippocampal plasticity. Annual Review of Neuroscience, 22, 105-122.

[15]   Duman, S. R., Malberg, J., Nagakawa, S., & D’Sa, C. (2000). Neuronal plasticity and survival in mood disorder. Biological Psychiatry, 48, 732-739.

[16]   Chaouloff, F. (2000). Serotonin, stress and corticoids. Journal of Psychopharmacology, 14, 139-151.

[17]   Bianchi, M., Heidbreder, C., & Crespi, F. (2003). Cytoskeletal changes in the hippocampus following restraint stress: Role of serotonin and microtubules. Synapse, 49, 188-194.

[18]   Heron, D. S., Shinitzky, M., Hershkowitz, M., & Samuel, D. (1980). Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proceedings of the National Academy of Sciences, 77, 7463-7467.

[19]   Lee, R. E. (1985). Membrane engineering to rejuvenate the ageing brain. Canadian Medical Association Journal, 132, 325-327.

[20]   Cowburn, R. F., Marcusson, J. O., Eriksson, A., Wiehager, B., & O’Neill, C. (1994). Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Research, 633, 297-304.

[21]   Pacheco, M. A., Stockmeier, C., Meltzer, H. Y., Overholser, J. C., Dilley, G. E., & Jope, R. S. (1996). Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Research, 723, 37-45.

[22]   Dowlatshahi, D., MacQueen, G. M., Wang, J. F., Reiach, J. S., & Young, L. T. (1999). G proteincoupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: Effects of diagnosis, suicide, and treatment at the time of death. Journal of Neurochemistry, 73, 1121-1126.

[23]   Stewart, R. J., Chen, B., Dowlatshahi, D., MacQueen G. M., & Young, L. T. (2001). Abnormalities in the cAMP signaling pathway in post-mortem brain tissue. Brain Research Bulletin, 55, 625-629.

[24]   Dwivedi, Y., Rizavi, H. S., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2002). mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims. Neuropsychopharmacology, 27, 499-517.

[25]   Dwivedi, Y., Rizavi, H. S., Shukla, P. K., Lyons, J., Faludi, G., Palkovits, M., Sarosi, A., Conley, R. R., Roberts, R. C., Tamminga, C. A., & Pandey, G. N. (2004). Protein kinase A in postmortem brain of depressed suicide victims: Altered expression of specific regulatory and catalytic subunits. Biological Psychiatry, 55, 234-243.

[26]   Pandey, G. N., Dwivedi, Y., Ren, X., Rizavi, H. S., Monda, A. C., Shukla, P. K., & Conley, R. R. (2005). Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims. Neuropsychopharmacology, 30, 1548-1556.

[27]   Poulter, M. O., Du, L., Weaver, I. C. G., Palkovits, M., Faludi, G., Merali, Z., Szyf, M., & Anisman, H. (2008). GABAA receptor promoter hypermethylation in suicide brain: Implications for the involvement of epigenetic processes. Biological Psychiatics, 64, 645-652.

[28]   Quilter, C. L., Gilbert, C. L., Oliver, G. L., Jafer, O., Furlong, R. A., Blott, S. C., Wilson, A. E., Sargent, C. A., Mileham, A., & Affara, N. A. (2008). A model for puerperal psychosis. American Journal of Medical Genetics Part B, 147, 1126-1137.

[29]   Donati, R. J., Dwivedi, Y., Roberts, R. C., Conley, R. R., Pandey, G. N., & Rasenick, M. M. (2008). Postmortem brain tissue of depressed suicides reveals increased Gs localization in lipid raft domains where it is less likely to activate adenylyl cyclase. Journal of Neuroscience, 28, 3042-3050.

[30]   Popova, J. S., Greene, A. K., Wang, J., & Rasenick, M. M. (2002). Phosphatidylinositol 4, 5-bisphosphate modifies tubulin participation in phospholipase Cβ1 signaling. Journal of Neuroscience, 22, 1668-1678.

[31]   Hameroff, S. R., & Penrose, R. (1996). Orchestrated reduction of quantum coherence in brain microtubules: A model for consciousness. In S. R. Hameroff, A. Kaszniak, & A. C. Scott (Eds.), Toward a science of consciousness—The first Tucson discussions and debates (pp. 507-540). Cambridge, MA: MIT Press.

[32]   Hameroff, S. R. (2010). The “conscious pilot”-dendritic synchrony moves through the brain to mediate consciousness. Journal of Biological Physics, 36, 71-93.

[33]   Tonello, L., & Cocchi, M. (2010). The cell membrane: Is it a bridge from psychiatry to quantum consciousness? Neuro Quantology, 8, 54-60.